tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
PremiumPre-EarningsMineralys Therapeutics, Inc. (MLYS) Q2 Earnings Cheat Sheet
19d ago
3 Best Stocks to Buy Now, 7/15/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/15/2025, According to Top Analysts
2M ago
Promising Investment Opportunity in Mineralys Therapeutics Driven by Lorundrostat’s Clinical Success
Premium
Ratings
Promising Investment Opportunity in Mineralys Therapeutics Driven by Lorundrostat’s Clinical Success
2M ago
Mineralys Therapeutics Reports Positive Phase 2 Trial Results
PremiumCompany AnnouncementsMineralys Therapeutics Reports Positive Phase 2 Trial Results
2M ago
Mineralys announces its Phase 2 Explore-CKD trial met primary endpoint
Premium
The Fly
Mineralys announces its Phase 2 Explore-CKD trial met primary endpoint
2M ago
Cautious Outlook for Mineralys Therapeutics Amid Market Challenges and Competitive Pressures
Premium
Ratings
Cautious Outlook for Mineralys Therapeutics Amid Market Challenges and Competitive Pressures
3M ago
Mineralys Therapeutics Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsMineralys Therapeutics Approves Key Proposals at Annual Meeting
3M ago
Mineralys Therapeutics’ Earnings Call: Positive Outlook Amid Challenges
Premium
Company Announcements
Mineralys Therapeutics’ Earnings Call: Positive Outlook Amid Challenges
4M ago
Mineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
Premium
The Fly
Mineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100